Risk-Stratified Pathways for Cancer Survivorship Care: Insights from a Deliberative Multi-Stakeholder Consultation.
care coordination
deliberative consultation
multi-stakeholder
risk stratification
survivorship care
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
05 09 2021
05 09 2021
Historique:
received:
06
07
2021
revised:
31
08
2021
accepted:
02
09
2021
entrez:
30
9
2021
pubmed:
1
10
2021
medline:
28
10
2021
Statut:
epublish
Résumé
Risk-stratified pathways of survivorship care seek to optimize coordination between cancer specialists and primary care physicians based on the whole person needs of the individual. While the principle is supported by leading cancer institutions, translating knowledge to practice confronts a lack of clarity about the meaning of risk stratification, uncertainties around the expectations the model holds for different actors, and health system structures that impede communication and coordination across the care continuum. These barriers must be better understood and addressed to pave the way for future implementation. Recognizing that an innovation is more likely to be adopted when user experience is incorporated into the planning process, a deliberative consultation was held as a preliminary step to developing a pilot project of risk-stratified pathways for patients transitioning from specialized oncology teams to primary care providers. This article presents findings from the deliberative consultation that sought to understand the perspectives of cancer specialists, primary care physicians, oncology nurses, allied professionals, cancer survivors and researchers regarding the following questions: what does a risk stratified model of cancer survivorship care mean to care providers and users? What are the prerequisites for translating risk stratification into practice? What challenges are involved in establishing these prerequisites? The multi-stakeholder consultation provides empirical data to guide actions that support the development of risk-stratified pathways to coordinate survivorship care.
Identifiants
pubmed: 34590587
pii: curroncol28050295
doi: 10.3390/curroncol28050295
pmc: PMC8482148
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3408-3419Subventions
Organisme : CIHR
ID : MP-04-2019-263
Pays : Canada
Références
Fam Pract. 2018 Dec 12;35(6):749-752
pubmed: 30541124
J Natl Cancer Inst. 2021 May 4;113(5):523-531
pubmed: 32525530
J Oncol Pract. 2016 Nov;12(11):1012-1019
pubmed: 27650834
Asia Pac J Clin Oncol. 2015 Dec;11(4):319-27
pubmed: 26245952
CA Cancer J Clin. 2004 Jul-Aug;54(4):208-36
pubmed: 15253918
Semin Oncol. 2013 Dec;40(6):804-12
pubmed: 24331199
Am Soc Clin Oncol Educ Book. 2016;35:231-9
pubmed: 27249703
Collegian. 2010;17(2):47-50
pubmed: 20738055
J Natl Cancer Inst Monogr. 2010;2010(40):18-24
pubmed: 20386050
BMC Health Serv Res. 2017 Dec 16;17(1):834
pubmed: 29246224
J Natl Cancer Inst. 2019 May 1;111(5):442-448
pubmed: 30726949
Cancer. 2011 May 15;117(10 Suppl):2250-7
pubmed: 21523742
Lancet Oncol. 2015 Sep;16(12):1231-72
pubmed: 26431866
Br J Cancer. 2012 Jan 3;106(1):1-5
pubmed: 22215103
Cancer Med. 2018 Oct;7(10):5291-5298
pubmed: 30207076
Curr Oncol. 2019 Feb;26(1):48-54
pubmed: 30853798
CA Cancer J Clin. 2019 May;69(3):234-247
pubmed: 30849190
Curr Oncol. 2012 Dec;19(6):294-301
pubmed: 23300354
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Eur J Cancer. 2015 Apr;51(6):758-66
pubmed: 25736818
CA Cancer J Clin. 2012 Mar-Apr;62(2):101-17
pubmed: 22241452
F1000Res. 2016 Mar 16;5:361
pubmed: 27239275
Res Nurs Health. 1997 Apr;20(2):169-77
pubmed: 9100747
Br J Gen Pract. 2015 Nov;65(640):e761-8
pubmed: 26500324
Support Care Cancer. 2017 Apr;25(4):1323-1355
pubmed: 28058570